Jiaqi Feng

Jiaqi Feng

Auto-generated profile, based on publicly available information

Jiaqi Feng

Department of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2024 in Journal of Water Process Engineering
Verified
Journal Article
Closed access
PXPeng Xu
Peng Xu
JYJiafan Yao
Jiafan Yao
NLNa Li
Na Li
JFJiaqi Feng
Jiaqi Feng
RWRuoxi Wu
Ruoxi Wu
BHBaolin Hou
Baolin Hou

25 September 2020 in Research Square
Verified
Preprint
Open access
PDF file
JLJia Li
Jia Li
LRLiu Rong
Liu Rong
RCRan Cui
Ran Cui
JFJiaqi Feng
Jiaqi Feng
YJYuyang Jin
Yuyang Jin
RXRENYING XU
RENYING XU
Background: Biomarkers that would help prognosticate outcomes and guide treatment of patients with severe coronavirus disease 2019 (COVID-19) are currently required. We aimed to investigate whether the dynamic variation of cytokines was associated with the survival of patients admitted to an intensive care unit (ICU).Methods: A retrospective study was performed on 40 patients with COVID-19 admitted to an ICU in Wuhan, China. Demographic, clinical, and laboratory variables were collected, and serum cytokines were kinetically assessed. A multivariable- adjusted generalized linear regression model was used to evaluate the differences in serum cytokine levels between survivor and non-survivors.Results: Among the 40 patients included, a significant positive correlation was found between multiple cytokines. Serum levels of IL-6, IL-10, and tumor necrosis factor alpha in non-survivors were consistently elevated compared to that of the survivors. Kinetic variations of IL-6, IL-8, and IL-10 were associated with a fatal outcome in severe patients with COVID-19, independent of sex, age, absolute lymphocyte count, direct bilirubin, hypertension, chronic obstructive pulmonary disease, and cancer.Conclusion: Dynamic changes in serum IL-6, IL-8, and IL-10 levels were associated with survival in ICU and could serve as a predictive biomarker in patients with severe COVID-19 to determine therapeutic options.